These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37955745)

  • 21. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001145. PubMed ID: 19160189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort.
    Zayat N; Truffert P; Drumez E; Duhamel A; Labreuche J; Zemlin M; Milligan D; Maier RF; Jarreau PH; Torchin H; Zeitlin J; Nuytten A;
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016-17 cohort.
    Douglas E; Hodgson KA; Olsen JE; Manley BJ; Roberts CT; Josev E; Anderson PJ; Doyle LW; Davis PG; Cheong JLY;
    Acta Paediatr; 2023 Jun; 112(6):1226-1232. PubMed ID: 36719082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
    Williams MJ; Ramson JA; Brownfoot FC
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006764. PubMed ID: 35943347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes.
    Harmon HM; Jensen EA; Tan S; Chaudhary AS; Slaughter JL; Bell EF; Wyckoff MH; Hensman AM; Sokol GM; DeMauro SB;
    J Perinatol; 2020 Apr; 40(4):616-627. PubMed ID: 32020038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm.
    Qin G; Lo JW; Marlow N; Calvert SA; Greenough A; Peacock JL
    PLoS One; 2017; 12(7):e0181176. PubMed ID: 28723921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.
    Nath S; Reynolds AM; Lakshminrusimha S; Ma C; Hudak ML; Ryan RM
    Am J Perinatol; 2020 Dec; 37(14):1425-1431. PubMed ID: 31382299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of postnatal hydrocortisone on cytokine profile in extremely preterm infants.
    Tamura K; Nagaoka M; Inomata S; Kawasaki Y; Makimoto M; Yoshida T
    Pediatr Int; 2022 Jan; 64(1):e15205. PubMed ID: 35831259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants.
    Esterman E; Goyen TA; Jani P; Lowe G; Baird J; Maheshwari R; D'Cruz D; Luig M; Shah D
    World J Pediatr; 2023 Jun; 19(6):586-594. PubMed ID: 36967444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
    Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of sex on the requirement for and outcomes following late postnatal corticosteroid treatment.
    Lee R; Kostina E; Dassios T; Greenough A
    Eur J Pediatr; 2023 Mar; 182(3):1417-1423. PubMed ID: 36692623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Wilson-Costello D; Walsh MC; Langer JC; Guillet R; Laptook AR; Stoll BJ; Shankaran S; Finer NN; Van Meurs KP; Engle WA; Das A;
    Pediatrics; 2009 Mar; 123(3):e430-7. PubMed ID: 19204058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.